Tiamat's proprietary platform enables the production of a wide range of high-value proteins, achieving a 10x cost reduction with the potential to reduce costs 1000x at scale. The company's low investment needs and unique technology make it an ideal partner for production scale-up in promising markets such as cellular agriculture or cell & gene therapy. Tiamat's plant molecular farming technology creates ecological alternatives while increasing the safety and speed of production, helping to reduce or replace animal-based raw materials and move towards sustainability.